NEJM at ESMO — Ponsegromab in Cancer Cachexia

NEJM Interviews
13/09/2024 2 min

Listen "NEJM at ESMO — Ponsegromab in Cancer Cachexia"

Descargar episodio Ver en sitio original

Episode Synopsis


Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.

More episodes of the podcast NEJM Interviews

NEJM Interview: Robert Huckman on the dearth of successful business models aimed at keeping people healthy. 03/12/2025
NEJM Interview: Nishant Uppal on the emergence of venture capital investing by academic medical centers and its potential implications. 26/11/2025
NEJM Interview: Jane Zhu on a new Oregon law that aims to address corporate control in medicine. 19/11/2025
NEJM Interview: Joshua Barocas on recent federal actions related to harm-reduction programs for people with substance use disorders. 12/11/2025
NEJM Interview: Yashaswini Singh on antitrust enforcement as a potential counterbalance to consolidation resulting from rapid health care corporatization. 05/11/2025
NEJM Interview: Eberechi Nwogu-Onyemkpa on integrating palliative care services and resources into the management of sickle cell disease. 22/10/2025
NEJM Interview: Michael Liu on a new model that will expand the use of prior authorization in traditional Medicare. 15/10/2025
NEJM Interview: Andrew Gabrielson on cuts to the U.S. research agency charged with safeguarding workers’ health. 08/10/2025
NEJM Interview: Steven Lipstein on the drivers and the benefits of mergers and consolidation, from the perspective of a health care system leader. 01/10/2025
NEJM Interview: Nancy Krieger on the effects of structural racism on health and health care and the conflation of research on health equity with DEI work. 24/09/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA